Evotec SE (EVO) Cash from Operations (QoQ) (2009 - 2026)
Powered by 
Analysis
Evotec SE (EVO) Cash from Operations (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 25.01% |
| Dec 31, 2025 | 92.26% |
| Sep 30, 2025 | -362.73% |
| Jun 30, 2025 | 189.84% |
| Mar 31, 2025 | -142.19% |
| Dec 31, 2024 | 69.53% |
| Sep 30, 2024 | 186.16% |
| Jun 30, 2024 | -3.75% |
| Mar 31, 2024 | -343.90% |
| Jun 30, 2023 | -1,104.96% |
| Mar 31, 2023 | 102.14% |
| Dec 31, 2022 | -684.80% |
| Sep 30, 2022 | -102.12% |
| Jun 30, 2022 | 164.50% |
| Mar 31, 2022 | -3.53% |
| Dec 31, 2021 | 201.77% |
| Sep 30, 2021 | -50.45% |
| Jun 30, 2021 | 1,668,691.98% |
| Sep 30, 2010 | 167.85% |
| Jun 30, 2010 | -91,089.87% |